Search research articles
Contact Us
Filters
Showing results (41-50 of 263) with videos related to
Page
of 27
Sort By:
Journal of Crohn'S & Colitis
|
June 17, 2021
Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?
Robert J Gianotti, Adam S Cheifetz
Journal of Clinical Gastroenterology
|
August 31, 2006
Capsule endoscopy retention: is it a complication?
Adam S Cheifetz, Blair S Lewis
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 12, 2015
It Is Time to Treat to Trough: Staying Ahead of the Curve in Biologic Testing
Byron P Vaughn, Adam S Cheifetz
Gastroenterology Clinics of North America
|
August 12, 2014
Miscellaneous adverse events with biologic agents (excludes infection and malignancy)
Joseph D Feuerstein, Adam S Cheifetz
Mayo Clinic Proceedings
|
September 10, 2014
Ulcerative colitis: epidemiology, diagnosis, and management
Joseph D Feuerstein, Adam S Cheifetz
Annals of Translational Medicine
|
February 5, 2020
The cost and benefit of anti-TNF therapy from a population perspective-for what it's worth
Joseph D Frasca, Adam S Cheifetz
Alimentary Pharmacology & Therapeutics
|
August 16, 2019
Editorial: real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease-results from the ENEIDA registry
Joseph D Frasca, Adam S Cheifetz
Gastroenterology & Hepatology
|
January 2, 2020
Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease
Sean Fine, Kostantinos Papamichael, Adam S Cheifetz
Expert Review of Gastroenterology & Hepatology
|
January 31, 2022
Choosing the right biologic for complications of inflammatory bowel disease
Shana Rakowsky, Konstantinos Papamichael, Adam S Cheifetz
Gastroenterology & Hepatology
|
April 8, 2014
Varicella zoster virus infection in patients with inflammatory bowel disease
Maggie Ham, Garret Cullen, Adam S Cheifetz
Page
of 27
Search research articles
Search
Showing results (41-50 of 263) with videos related to
Sort By:
Page
of 27
Journal of Crohn'S & Colitis
|
June 17, 2021
Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?
Robert J Gianotti, Adam S Cheifetz
Journal of Clinical Gastroenterology
|
August 31, 2006
Capsule endoscopy retention: is it a complication?
Adam S Cheifetz, Blair S Lewis
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 12, 2015
It Is Time to Treat to Trough: Staying Ahead of the Curve in Biologic Testing
Byron P Vaughn, Adam S Cheifetz
Gastroenterology Clinics of North America
|
August 12, 2014
Miscellaneous adverse events with biologic agents (excludes infection and malignancy)
Joseph D Feuerstein, Adam S Cheifetz
Mayo Clinic Proceedings
|
September 10, 2014
Ulcerative colitis: epidemiology, diagnosis, and management
Joseph D Feuerstein, Adam S Cheifetz
Annals of Translational Medicine
|
February 5, 2020
The cost and benefit of anti-TNF therapy from a population perspective-for what it's worth
Joseph D Frasca, Adam S Cheifetz
Alimentary Pharmacology & Therapeutics
|
August 16, 2019
Editorial: real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease-results from the ENEIDA registry
Joseph D Frasca, Adam S Cheifetz
Gastroenterology & Hepatology
|
January 2, 2020
Etiology and Management of Lack or Loss of Response to Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease
Sean Fine, Kostantinos Papamichael, Adam S Cheifetz
Expert Review of Gastroenterology & Hepatology
|
January 31, 2022
Choosing the right biologic for complications of inflammatory bowel disease
Shana Rakowsky, Konstantinos Papamichael, Adam S Cheifetz
Gastroenterology & Hepatology
|
April 8, 2014
Varicella zoster virus infection in patients with inflammatory bowel disease
Maggie Ham, Garret Cullen, Adam S Cheifetz
Page
of 27